#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Ovarian epithelial cancer Leiomyosarcoma recurrent Mantle cell lymphoma refractory Angiosarcoma recurrent Dermatitis Proteus syndrome Cystic fibrosis lung Acute graft versus host disease Acute lymphocytic leukaemia Hodgkin's disease refractory Diabetes insipidus Hyperadrenocorticism Haemophilia B without inhibitors Squamous cell carcinoma of head and neck Warm autoimmune haemolytic anaemia More trials…

    Learn about Rare Diseases

    X-linked lymphoproliferative syndrome – Life with Disease Short-bowel syndrome – Trials in Disease Mucopolysaccharidosis – Life with Disease Antithrombin III deficiency – Diagnostics Netherton’s syndrome – Diagnostics Congenital generalised lipodystrophy – Basic Information X-linked lymphoproliferative syndrome Nephroblastoma – Trials in Disease Antisynthetase syndrome Vascular malformation – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    IMEROPRUBART Pf-06835375 Ibrutinib ARFOLITIXORIN [18F]CPFPX Inupadenant Hydrochloride Cft1946 Nifedipine Aclidinium Bromide Vamorolone LTG-001 Asp1570 Ubiquinol Pegargiminase Tumour Detection Mb-Cart20.1 Fenofibrate Micronised Ketoprofen 10-1074-Ls Concizumab More therapies…

    Learn about Your Condition

    Bone marrow disorder Lung adenocarcinoma stage IV Injection site pain Cardiac failure acute Appendicitis Cold type haemolytic anaemia Gastric cancer Malignant melanoma of eyelid Deafness neurosensory Coma Postoperative delirium EGFR gene mutation Elderly Demyelination Arteriosclerosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Reproductive and Urinary Physiological Phenomena

  • Study on Reducing Tacrolimus Dose in Kidney Transplant Patients Using LCPT Compared to Tacrolimus-ER

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Renal failure
    • Renal transplant
    Investigated Drugs:
    • Tacrolimus
    The Netherlands

  • Study of Capivasertib and Abiraterone for Patients with Metastatic Hormone-Sensitive Prostate Cancer with PTEN Deficiency

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Hormone-dependent prostate cancer
    Investigated Drugs:
    • Capivasertib
    • Abiraterone Acetate
    Belgium Bulgaria Czechia France Germany The Netherlands +3

  • Study on the Effect of Oil-Based Tubal Flushing with Ethyl Esters of Iodised Fatty Acids on Pregnancy in Infertile Women with One Open Fallopian Tube

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Infertility female
    Investigated Drugs:
    • Ethyl Esters Of Iodised Fatty Acids From Poppyseed Oil
    Belgium

  • Study on the Effect of Dapagliflozin in Reducing Proteinuria in Patients with Chronic Kidney Disease After Kidney Transplant

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic kidney disease
    Investigated Drugs:
    • Dapagliflozin
    France

  • Study on Progesterone for Improving Birth Rates in Couples with Unexplained Infertility Undergoing Mild Ovarian Stimulation and Intrauterine Insemination

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Infertility
    • Infertility female
    Investigated Drugs:
    • Progesterone, Micronised
    The Netherlands

  • Study of Imlifidase for Patients Undergoing Kidney Transplant from a Living Donor

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Renal transplant
    Investigated Drugs:
    • Imlifidase
    Spain
Previous Page
1 … 4 5 6

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!